speb/financial-data huggingface dataset:
Financial ratios for ALC.TO — quarterly report dated 2025-06-30
Total revenue: 154536496.35036495
Gross profit: 139823357.66423357
Operating income: 25668613.138686128
Net income: 24002189.781021897
Capital expenditures: 18654744.525547445
Operating cash flow: 21295620.437956203
Depreciation & amortization: 14713138.686131386
Net tangible assets: 637750364.9635036
Owner earnings: 20060583.941605836
Return on net tangible assets (%): 3.14552292616153
Capex to operating income (%): 72.67531138031053
Buffett classification: The Good
Stock price: 11.306569343065693
P/E ratio: 10.485246206574182
Shares outstanding: 40567816
Book value: 643524087.5912409
P/B ratio: 0.7127671419691751
Market cap (USD): 458682824.7007299
Debt to equity: 0.6944085260449986
Current ratio: 0.5933306185511447
Quick ratio: 0.5485666548893028
Effective tax rate (%): 21.012800149490797
Interest coverage ratio: 5.527507073247406
COGS to revenue (%): 9.520818080910658
SG&A to revenue (%): 5.754906359965047
Free cash flow (dilution-adjusted): 2640875.912408759
Buyback yield (%): 0
Retained earnings: 606081021.8978102
Inventory turnover: 1.348294314381271
Receivables turnover: 1.6860719775100144
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.53257177096379
FCF margin (%): 1.708901117067756
Revenue growth (%): 106.14284361248669
Rule of 40 score: 107.85174472955444
Financial ratios for ALC.TO — quarterly report dated 2025-12-31
Total revenue: 156281021.89781022
Gross profit: 137771532.84671533
Operating income: 21859854.014598537
Net income: 68602189.7810219
Capital expenditures: 8294160.583941605
Operating cash flow: 51544525.54744525
Depreciation & amortization: 18509489.05109489
Net tangible assets: 730240875.9124087
Owner earnings: 78817518.24817517
Return on net tangible assets (%): 10.793358855692052
Capex to operating income (%): 37.942433551489245
Buffett classification: The Good
Stock price: 13.532846715328466
P/E ratio: 4.886596330699006
Shares outstanding: 40567816
Book value: 736014598.540146
P/B ratio: 0.7459064488565363
Market cap (USD): 548998035.5036496
Debt to equity: 0.5320011107364578
Current ratio: 0.7131299346914904
Quick ratio: 0.653759300776554
Effective tax rate (%): 24.496574631513386
Interest coverage ratio: 4.530711043872919
COGS to revenue (%): 11.843721538497466
SG&A to revenue (%): 9.171668106770042
Free cash flow (dilution-adjusted): 43250364.963503644
Buyback yield (%): 0
Retained earnings: 694002919.7080292
Inventory turnover: 1.734710630729238
Receivables turnover: 2.0908895594683545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9644628229280907
FCF margin (%): 27.674739029915223
Revenue growth (%): 1.1288760834140315
Rule of 40 score: 28.803615113329254
Financial ratios for ALC.TO — annual report dated 2025-12-31
Total revenue: 555515328.4671532
Gross profit: 492793430.65693426
Operating income: 58538686.131386854
Net income: 104397810.21897809
Capital expenditures: 189194890.5109489
Operating cash flow: 122110948.90510948
Depreciation & amortization: 62721897.810218975
Net tangible assets: 730240875.9124087
Owner earnings: -22075182.48175183
Return on net tangible assets (%): -3.0230001099527213
Capex to operating income (%): 323.19633906082447
Buffett classification: The Gruesome
Stock price: 13.532846715328466
P/E ratio: 5.2587121736759315
Shares outstanding: 40567816
Book value: 736014598.540146
P/B ratio: 0.7459064488565363
Market cap (USD): 548998035.5036496
Debt to equity: 0.5320011107364578
Current ratio: 0.7131299346914904
Quick ratio: 0.653759300776554
Effective tax rate (%): 14.524063763252231
Interest coverage ratio: 3.242026114726927
COGS to revenue (%): 11.290759155699451
SG&A to revenue (%): 6.818289324307279
Free cash flow (dilution-adjusted): -67083941.60583941
Buyback yield (%): 0
Retained earnings: 694002919.7080292
Inventory turnover: 5.878300725133397
Receivables turnover: 7.432260080664849
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.260651444944138
FCF margin (%): -12.075983896060212
Revenue growth (%): 12.928238737984685
Rule of 40 score: 0.8522548419244735
Financial ratios for ALGEN.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.875
Shares outstanding: 12339118
Market cap (USD): 60153200.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALGEN.PA — annual report dated 2022-12-31
Total revenue: 18141686.170212768
Gross profit: 9232541.489361703
Operating income: 623285.1063829787
Net income: 827395.7446808511
Capital expenditures: 565872.340425532
Operating cash flow: 2505654.2553191492
Depreciation & amortization: 2910185.106382979
Net tangible assets: 11314689.361702127
Owner earnings: 3171708.5106382985
Return on net tangible assets (%): 28.031777181385753
Capex to operating income (%): 90.78868316128681
Buffett classification: The Gruesome
Stock price: 4.25531914893617
P/E ratio: 63.46042440263734
Shares outstanding: 12339118
Book value: 17197930.85106383
P/B ratio: 3.0530931634217504
Market cap (USD): 52506885.10638298
Debt to equity: 0.5595653361317898
Current ratio: 2.8341722912135827
Quick ratio: 2.6646944114925057
Effective tax rate (%): -2.983053642325304
Interest coverage ratio: 4.801140693758144
COGS to revenue (%): 49.108691426264365
Free cash flow (dilution-adjusted): 466600
Buyback yield (%): 0
Retained earnings: -804885.1063829787
Inventory turnover: 7.065017323836367
Receivables turnover: 2.1756698121018903
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.259564093044114
FCF margin (%): 2.571977023646902
Rule of 40 score: 2.571977023646902
Financial ratios for ALGEN.PA — annual report dated 2023-12-31
Total revenue: 22273757.777777776
Gross profit: 11622636.666666666
Operating income: 173493.33333333334
Net income: 1741750
Capital expenditures: 166000
Operating cash flow: 3403845.5555555555
Depreciation & amortization: 4763226.666666667
Net tangible assets: 13029903.333333332
Owner earnings: 6338976.666666667
Return on net tangible assets (%): 48.6494527587951
Capex to operating income (%): 95.68090992929604
Buffett classification: The Gruesome
Stock price: 5.111111111111111
P/E ratio: 36.20875734813326
Shares outstanding: 12339118
Book value: 19314285.555555556
P/B ratio: 3.2652827322919356
Market cap (USD): 63066603.111111104
Debt to equity: 0.41612279270317876
Current ratio: 2.650244474838748
Quick ratio: 2.50334267584475
Effective tax rate (%): -1.0217446384202955
Interest coverage ratio: 1.431607514509164
COGS to revenue (%): 47.81914761476659
Free cash flow (dilution-adjusted): 1422498.8888888888
Buyback yield (%): 0.12869991828110158
Retained earnings: 901092.2222222222
Inventory turnover: 9.754260234789891
Receivables turnover: 3.900556197117737
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6207886923457371
FCF margin (%): 6.3864342203994715
Revenue growth (%): 22.776667884099698
Rule of 40 score: 29.16310210449917
Financial ratios for ALGEN.PA — annual report dated 2024-12-31
Total revenue: 22978106.25
Gross profit: 11129720.833333334
Operating income: 1459108.3333333335
Net income: 1907014.5833333335
Capital expenditures: 655993.75
Operating cash flow: 5606321.875
Depreciation & amortization: 3093550
Net tangible assets: 13332000
Owner earnings: 4344570.833333334
Return on net tangible assets (%): 32.5875400040004
Capex to operating income (%): 44.95853632069814
Buffett classification: The Good
Stock price: 3.90625
P/E ratio: 25.27494026985897
Shares outstanding: 12339118
Book value: 19348818.75
P/B ratio: 2.4910915911856373
Market cap (USD): 48199679.6875
Debt to equity: 0.30016297291189076
Current ratio: 2.4368086771583233
Quick ratio: 2.28460408063887
Effective tax rate (%): -1.021655023729688
Interest coverage ratio: 9.560544115539235
COGS to revenue (%): 51.56380289897331
Free cash flow (dilution-adjusted): 3119122.916666667
Buyback yield (%): 0.21945166583219317
Retained earnings: 2709548.9583333335
Inventory turnover: 10.433112033651739
Receivables turnover: 3.4672245708364975
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.685449586538292
FCF margin (%): 13.574325415379551
Revenue growth (%): 3.16223458676983
Rule of 40 score: 16.736560002149382
Financial ratios for ALGEN.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 13332000
Buffett classification: The Gruesome
Stock price: 3.90625
Shares outstanding: 12339118
Book value: 19348818.75
P/B ratio: 2.4910915911856373
Market cap (USD): 48199679.6875
Debt to equity: 0.30016297291189076
Current ratio: 2.4368086771583233
Quick ratio: 2.28460408063887
Buyback yield (%): 0
Retained earnings: 2709548.9583333335
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALGEN.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 14574394.11764706
Buffett classification: The Gruesome
Stock price: 3.8823529411764706
Shares outstanding: 12339118
Book value: 21635438.82352941
P/B ratio: 2.214182547881817
Market cap (USD): 47904811.058823526
Debt to equity: 0.7878882593661827
Current ratio: 2.5040301472144066
Quick ratio: 2.299701061112246
Buyback yield (%): 0
Retained earnings: 3143541.1764705884
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMRX — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 60700000
Buffett classification: The Gruesome
Stock price: 4.79
Shares outstanding: 319331346
Market cap (USD): 1529597147.34
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMRX — annual report dated 2022-12-31
Total revenue: 2212304000
Gross profit: 784708000
Operating income: 188922000
Net income: -129986000
Capital expenditures: 48795000
Operating cash flow: 65100000
Depreciation & amortization: 240175000
Net tangible assets: -1396525000
Owner earnings: 61394000
Capex to operating income (%): 25.82811954139804
Buffett classification: The Good
Stock price: 1.99
Shares outstanding: 319331346
Book value: 183979000
P/B ratio: 3.454032137037379
Market cap (USD): 635469378.54
Debt to equity: 15.464455182384945
Current ratio: 1.875422422954304
Quick ratio: 1.1704078108395324
Interest coverage ratio: 1.1928625999987372
COGS to revenue (%): 64.52982953518142
R&D to revenue (%): 9.042428165387758
SG&A to revenue (%): 18.067137246960634
Free cash flow (dilution-adjusted): -57342000
Buyback yield (%): 0
Retained earnings: -406183000
Inventory turnover: 2.689847098834635
Receivables turnover: 2.776102696665872
Capitalized R&D asset: 200046000
ROCI (R&D-adjusted, %): 9.926917097863079
FCF margin (%): -2.5919584288596864
Rule of 40 score: -2.5919584288596864
Financial ratios for AMRX — annual report dated 2023-12-31
Total revenue: 2393607000
Gross profit: 820565000
Operating income: 238747000
Net income: -48722000
Capital expenditures: 46801000
Operating cash flow: 345577000
Depreciation & amortization: 229400000
Net tangible assets: -1469271000
Owner earnings: 133877000
Capex to operating income (%): 19.602759406400917
Buffett classification: The Great
Stock price: 6.07
Shares outstanding: 319331346
Book value: 20011000
P/B ratio: 96.86378842736495
Market cap (USD): 1938341270.22
Debt to equity: 137.45055219629205
Current ratio: 1.6275350078845257
Quick ratio: 0.9408028632344864
Interest coverage ratio: 1.133495387624686
COGS to revenue (%): 65.71847425245664
R&D to revenue (%): 7.009421346110703
SG&A to revenue (%): 17.950941821276427
Free cash flow (dilution-adjusted): 249566000
Buyback yield (%): 0
Retained earnings: -490176000
Inventory turnover: 2.705685054972273
Receivables turnover: 3.7072251649474954
Capitalized R&D asset: 301808820
ROCI (R&D-adjusted, %): 9.697338137942896
Rosenberg metric: 0.17924377393199564
FCF margin (%): 10.426356540568273
Revenue growth (%): 8.195211869616474
Rule of 40 score: 18.621568410184747
Financial ratios for AMRX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.32
Shares outstanding: 319331346
Market cap (USD): 2656836798.7200003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMRX — annual report dated 2024-12-31
Total revenue: 2793957000
Gross profit: 1020438000
Operating income: 348373000
Net income: -73876000
Capital expenditures: 60340000
Operating cash flow: 295099000
Depreciation & amortization: 236191000
Net tangible assets: -1439080000
Owner earnings: 101975000
Capex to operating income (%): 17.32051565419823
Buffett classification: The Great
Stock price: 7.92
Shares outstanding: 319331346
Book value: -109512000
Market cap (USD): 2529104260.32
Debt to equity: -23.679039739937174
Current ratio: 1.4054228688822779
Quick ratio: 0.8633183184910924
Interest coverage ratio: 1.3471760861578916
COGS to revenue (%): 63.47696117012538
R&D to revenue (%): 7.03514764185705
SG&A to revenue (%): 17.05237410597228
Free cash flow (dilution-adjusted): 192341000
Buyback yield (%): 0
Retained earnings: -607062000
Inventory turnover: 2.8957587018780186
Receivables turnover: 3.4554555978252806
Capitalized R&D asset: 374985440
ROCI (R&D-adjusted, %): 12.990483207970382
Rosenberg metric: 1.1912944486166244
FCF margin (%): 6.884178961952528
Revenue growth (%): 16.725803358696727
Rule of 40 score: 23.609982320649255
Financial ratios for AMRX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.92
Shares outstanding: 319331346
Market cap (USD): 2529104260.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMRX — quarterly report dated 2025-03-31
Total revenue: 695420000
Gross profit: 255891000
Operating income: 100918000
Net income: 24618000
Capital expenditures: 13598000
Operating cash flow: 7408000
Depreciation & amortization: 60159000
Net tangible assets: -1418300000
Owner earnings: 71179000
Return on net tangible assets (%): -5.018613833462596
Capex to operating income (%): 13.474305872094176
Buffett classification: The Great
Stock price: 8.38
P/E ratio: 27.175203910553257
Shares outstanding: 319331346
Book value: -59389000
Market cap (USD): 2675996679.48
Debt to equity: -43.43398609170048
Current ratio: 1.403993590029596
Quick ratio: 0.8449495456505897
Effective tax rate (%): 34.32748226004375
Interest coverage ratio: 1.7723879941691987
COGS to revenue (%): 63.203387880705186
R&D to revenue (%): 6.0117626757930465
SG&A to revenue (%): 17.00957694630583
Free cash flow (dilution-adjusted): -18172000
Buyback yield (%): 0
Retained earnings: -594867000
Inventory turnover: 0.730802932329952
Receivables turnover: 0.8689556587953927
Capitalized R&D asset: 41807000
ROCI (R&D-adjusted, %): 5.5245180802825855
FCF margin (%): -2.6130971211641882
Rule of 40 score: -2.6130971211641882
Financial ratios for AMRX — quarterly report dated 2025-06-30
Total revenue: 724508000
Gross profit: 286253000
Operating income: 112006000
Net income: 35610000
Capital expenditures: 25647000
Operating cash flow: 83819000
Depreciation & amortization: 60113000
Net tangible assets: -1359071000
Owner earnings: 70076000
Return on net tangible assets (%): -5.156169177327748
Capex to operating income (%): 22.89788047068907
Buffett classification: The Great
Stock price: 8.09
P/E ratio: 42.893514464036656
Shares outstanding: 319331346
Book value: -112533000
Market cap (USD): 2583390589.14
Debt to equity: -22.94342992722135
Current ratio: 1.4313461604467028
Quick ratio: 0.8813016310582098
Effective tax rate (%): 31.136508673202997
Interest coverage ratio: 1.7204958449178969
COGS to revenue (%): 60.49001529313686
R&D to revenue (%): 6.898612575706549
SG&A to revenue (%): 17.151777482098197
Free cash flow (dilution-adjusted): 48143000
Buyback yield (%): 0
Retained earnings: -572450000
Inventory turnover: 0.7196624480888315
Receivables turnover: 0.8531000335584299
Capitalized R&D asset: 77991690
ROCI (R&D-adjusted, %): 5.489158255497705
Rosenberg metric: 0.7262420168871242
FCF margin (%): 6.644923175451478
Revenue growth (%): 4.182796008167726
Rule of 40 score: 10.827719183619203
Financial ratios for AMRX — quarterly report dated 2025-09-30
Total revenue: 784513000
Gross profit: 273974000
Operating income: 70487000
Net income: 18132000
Capital expenditures: 15050000
Operating cash flow: 118450000
Depreciation & amortization: 54073000
Net tangible assets: -1293341000
Owner earnings: 57155000
Return on net tangible assets (%): -4.41917483478835
Capex to operating income (%): 21.351454878204493
Buffett classification: The Great
Stock price: 10.01
P/E ratio: 40.79258261179173
Shares outstanding: 319331346
Book value: -109955000
Market cap (USD): 3196506773.46
Debt to equity: -24.42566504479105
Current ratio: 2.1325428659584786
Quick ratio: 1.4197534873901818
Interest coverage ratio: 1.1221542968128124
COGS to revenue (%): 65.07718801345548
R&D to revenue (%): 8.385966835476276
SG&A to revenue (%): 17.566949177387755
Free cash flow (dilution-adjusted): 87767000
Buyback yield (%): 0
Retained earnings: -570081000
Inventory turnover: 0.8308201790073231
Receivables turnover: 0.848914176144879
Capitalized R&D asset: 113072580
ROCI (R&D-adjusted, %): 2.9377417285582954
Rosenberg metric: -0.2456733558752326
FCF margin (%): 11.187450048628895
Revenue growth (%): 8.28217217753289
Rule of 40 score: 19.469622226161786
Financial ratios for AMRX — quarterly report dated 2025-12-31
Total revenue: 814319000
Gross profit: 297190000
Operating income: 114503000
Net income: 49573000
Capital expenditures: 42454000
Operating cash flow: 130315000
Depreciation & amortization: 49227000
Net tangible assets: -1229762000
Owner earnings: 56346000
Return on net tangible assets (%): -4.581862181462754
Capex to operating income (%): 37.07675781420574
Buffett classification: The Good
Stock price: 12.6
P/E ratio: 31.450641817201188
Shares outstanding: 319331346
Book value: -71329000
Market cap (USD): 4023574959.6
Debt to equity: -37.69919668017216
Current ratio: 2.1677738923112
Quick ratio: 1.4800705055278103
Effective tax rate (%): 10.25074680908844
Interest coverage ratio: 2.036079449472767
COGS to revenue (%): 63.50447429078776
R&D to revenue (%): 4.4491163782252405
SG&A to revenue (%): 17.985334985429542
Free cash flow (dilution-adjusted): 75944000
Buyback yield (%): 0
Retained earnings: -535005000
Inventory turnover: 0.8529231307170354
Receivables turnover: 0.8664129447138659
Capitalized R&D asset: 96802360
ROCI (R&D-adjusted, %): 3.458375139260545
Rosenberg metric: 0.3528857407773336
FCF margin (%): 9.326074916586743
Revenue growth (%): 3.7992996929305187
Rule of 40 score: 13.125374609517262
Financial ratios for AMRX — annual report dated 2025-12-31
Total revenue: 3018760000
Gross profit: 1113308000
Operating income: 397914000
Net income: 127933000
Capital expenditures: 96749000
Operating cash flow: 339992000
Depreciation & amortization: 223572000
Net tangible assets: -1229762000
Owner earnings: 254756000
Return on net tangible assets (%): -20.71587835695037
Capex to operating income (%): 24.314047759063516
Buffett classification: The Great
Stock price: 12.6
P/E ratio: 31.450641817201188
Shares outstanding: 319331346
Book value: -71329000
Market cap (USD): 4023574959.6
Debt to equity: -37.69919668017216
Current ratio: 2.1677738923112
Quick ratio: 1.4800705055278103
Effective tax rate (%): 8.100051002449554
Interest coverage ratio: 1.6504722283287223
COGS to revenue (%): 63.120354052657376
R&D to revenue (%): 6.420086393088553
SG&A to revenue (%): 17.451768275715857
Free cash flow (dilution-adjusted): 193682000
Buyback yield (%): 0
Retained earnings: -535005000
Inventory turnover: 3.142744045046858
Receivables turnover: 3.211877336749394
Capitalized R&D asset: 380868270
ROCI (R&D-adjusted, %): 12.766988213403613
Rosenberg metric: 0.4724790012159199
FCF margin (%): 6.415945620055917
Revenue growth (%): 8.046043657794304
Rule of 40 score: 14.46198927785022
Financial ratios for APAM.AS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 40.44318181818182
Shares outstanding: 72341663
Market cap (USD): 2925727029.7386365
Buyback yield (%): 4.078240403337999
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APAM.AS — annual report dated 2022-12-31
Total revenue: 8676595744.680851
Gross profit: 1255319148.9361703
Operating income: 946808510.6382979
Net income: 665957446.8085107
Capital expenditures: 303191489.36170214
Operating cash flow: 682978723.4042554
Depreciation & amortization: 197872340.42553192
Net tangible assets: 3121276595.744681
Owner earnings: 560638297.8723404
Return on net tangible assets (%): 17.96182685753238
Capex to operating income (%): 32.02247191011236
Buffett classification: The Good
Stock price: 24.829787234042556
P/E ratio: 2.697211524632588
Shares outstanding: 72341663
Book value: 3608510638.297873
P/B ratio: 0.49777547594929245
Market cap (USD): 1796228100.4468086
Debt to equity: 0.2727004716981132
Current ratio: 1.9741796664873588
Quick ratio: 0.5798816568047338
Effective tax rate (%): 16.75531914893617
Interest coverage ratio: 40.45454545454545
COGS to revenue (%): 85.5321235899951
SG&A to revenue (%): 1.324178518881805
Free cash flow (dilution-adjusted): 368085106.38297874
Buyback yield (%): 11.489797908855055
Retained earnings: 2917021276.5957446
Inventory turnover: 2.6913580246913584
Receivables turnover: 17.9647577092511
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.236471123237834
FCF margin (%): 4.242275625306522
Rule of 40 score: 4.242275625306522
Financial ratios for APAM.AS — annual report dated 2023-12-31
Total revenue: 7324444444.444445
Gross profit: 421111111.1111111
Operating income: 98888888.88888888
Net income: 226666666.66666666
Capital expenditures: 277777777.7777778
Operating cash flow: 523333333.3333333
Depreciation & amortization: 226666666.66666666
Net tangible assets: 3322222222.2222223
Owner earnings: 175555555.55555552
Return on net tangible assets (%): 5.284280936454849
Capex to operating income (%): 280.8988764044944
Buffett classification: The Gruesome
Stock price: 30.88888888888889
P/E ratio: 9.85832466372549
Shares outstanding: 72341663
Book value: 3833333333.3333335
P/B ratio: 0.5829270235942029
Market cap (USD): 2234553590.4444447
Debt to equity: 0.2707246376811594
Current ratio: 1.7822798487304161
Quick ratio: 0.5499729875742843
Effective tax rate (%): -74.35897435897436
Interest coverage ratio: 2.069767441860465
COGS to revenue (%): 94.2506067961165
SG&A to revenue (%): 1.6535194174757282
Free cash flow (dilution-adjusted): 188888888.8888889
Buyback yield (%): 0
Retained earnings: 3134444444.444444
Inventory turnover: 2.723805348531346
Receivables turnover: 15.365967365967368
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.039880815952326
FCF margin (%): 2.578883495145631
Revenue growth (%): -15.583891886000758
Rule of 40 score: -13.005008390855128
Financial ratios for APAM.AS — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 64444444.44444444
Buffett classification: The Gruesome
Stock price: 27.977777777777778
Shares outstanding: 72341663
Market cap (USD): 2023958971.488889
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APAM.AS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.9375
Shares outstanding: 72341663
Market cap (USD): 1731678558.0625
Buyback yield (%): 0
Retained earnings: 3035416666.666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APAM.AS — annual report dated 2024-12-31
Total revenue: 6515625000
Gross profit: 467708333.3333334
Operating income: 134375000
Net income: 241666666.6666667
Capital expenditures: 144791666.6666667
Operating cash flow: 291666666.6666667
Depreciation & amortization: 238541666.6666667
Net tangible assets: 3048958333.3333335
Owner earnings: 335416666.6666667
Return on net tangible assets (%): 11.00102494021182
Capex to operating income (%): 107.75193798449614
Buffett classification: The Gruesome
Stock price: 23.9375
P/E ratio: 7.1655664471551725
Shares outstanding: 72341663
Book value: 3506250000.0000005
P/B ratio: 0.49388336771836
Market cap (USD): 1731678558.0625
Debt to equity: 0.22578728461081402
Current ratio: 1.7082601054481548
Quick ratio: 0.443468072642062
Effective tax rate (%): -197.43589743589746
Interest coverage ratio: 2.74468085106383
COGS to revenue (%): 92.82174260591528
SG&A to revenue (%): 1.870503597122302
Free cash flow (dilution-adjusted): 119791666.66666667
Buyback yield (%): 0
Retained earnings: 3035416666.666667
Inventory turnover: 2.689207966651227
Receivables turnover: 16.2890625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0898203592814366
FCF margin (%): 1.8385291766586729
Revenue growth (%): -11.042741201456312
Rule of 40 score: -9.20421202479764
Financial ratios for APAM.AS — quarterly report dated 2025-03-31
Total revenue: 1802173913.0434783
Operating income: -11956521.739130434
Net income: -18478260.869565215
Capital expenditures: 43478260.86956522
Operating cash flow: -114130434.78260869
Depreciation & amortization: 66304347.82608695
Net tangible assets: 3044565217.391304
Owner earnings: 4347826.086956516
Buffett classification: The Gruesome
Stock price: 30.130434782608692
Shares outstanding: 72341663
Book value: 3629347826.086956
P/B ratio: 0.6005722966037735
Market cap (USD): 2179685759.086956
Debt to equity: 0.42527702905061404
Current ratio: 1.7623211446740858
Quick ratio: 0.3060413354531002
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -172826086.95652172
Buyback yield (%): 0
Inventory turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.25918944392082943
FCF margin (%): -9.589867310012062
Rule of 40 score: -9.589867310012062
Financial ratios for APAM.AS — quarterly report dated 2025-06-30
Total revenue: 1945882352.9411764
Operating income: 55294117.64705882
Net income: 22352941.17647059
Capital expenditures: 44705882.35294118
Operating cash flow: 230588235.29411766
Depreciation & amortization: 76470588.23529412
Net tangible assets: 3147058823.529412
Owner earnings: 54117647.05882353
Return on net tangible assets (%): 1.7196261682242993
Capex to operating income (%): 80.85106382978724
Buffett classification: The Gruesome
Stock price: 30.494117647058825
P/E ratio: 569.3360503508907
Shares outstanding: 72341663
Book value: 3764705882.3529415
P/B ratio: 0.5859674703
Market cap (USD): 2205995182.3058825
Debt to equity: 0.43187499999999995
Current ratio: 1.7239459029435162
Quick ratio: 0.35799522673031037
Effective tax rate (%): 32.142857142857146
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 184705882.3529412
Buyback yield (%): 0
Inventory turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1471808640468635
FCF margin (%): 9.492140266021766
Revenue growth (%): 7.9741715745405495
Rule of 40 score: 17.466311840562316
Financial ratios for APAM.AS — quarterly report dated 2025-09-30
Total revenue: 1658823529.4117649
Operating income: 1582352941.1764705
Net income: -24705882.352941178
Capital expenditures: 29411764.705882356
Operating cash flow: 196470588.23529413
Depreciation & amortization: 76470588.23529412
Net tangible assets: 3156470588.2352943
Owner earnings: 22352941.176470585
Capex to operating income (%): 1.858736059479554
Buffett classification: The Great
Stock price: 31.28235294117647
Shares outstanding: 72341663
Book value: 3775294117.6470594
P/B ratio: 0.5994281144188219
Market cap (USD): 2263017434.317647
Debt to equity: 0.42536615768152064
Current ratio: 1.9188458070333634
Quick ratio: 0.4643823264201985
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 162352941.17647058
Buyback yield (%): 0
Inventory turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 32.09257933667382
FCF margin (%): 9.787234042553191
Revenue growth (%): -14.752116082224898
Rule of 40 score: -4.964882039671707
Financial ratios for APAM.AS — quarterly report dated 2025-12-31
Total revenue: 1597647058.8235295
Operating income: -34117647.05882353
Net income: 34117647.05882353
Capital expenditures: 45882352.941176474
Operating cash flow: 192941176.47058824
Depreciation & amortization: 80000000
Net tangible assets: 3164705882.352941
Owner earnings: 68235294.11764705
Return on net tangible assets (%): 2.1561338289962824
Buffett classification: The Gruesome
Stock price: 40.56470588235294
P/E ratio: 220.86557237928767
Shares outstanding: 72341663
Book value: 3776470588.235294
P/B ratio: 0.7770531278006231
Market cap (USD): 2934518282.635294
Debt to equity: 0.4059190031152648
Current ratio: 1.8042553191489359
Quick ratio: 0.5714285714285714
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 131764705.88235295
Buyback yield (%): 0
Retained earnings: 3274117647.0588236
Inventory turnover: 0
Receivables turnover: 3.12183908045977
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6359649122807018
FCF margin (%): 8.24742268041237
Revenue growth (%): -3.687943262411352
Rule of 40 score: 4.559479418001018
Financial ratios for APAM.AS — annual report dated 2025-12-31
Total revenue: 7152941176.470589
Gross profit: 401176470.5882353
Operating income: 18823529.411764707
Net income: 11764705.88235294
Capital expenditures: 161176470.5882353
Operating cash flow: 496470588.2352941
Depreciation & amortization: 304705882.35294116
Net tangible assets: 3164705882.352941
Owner earnings: 155294117.6470588
Return on net tangible assets (%): 4.907063197026022
Capex to operating income (%): 856.2499999999998
Buffett classification: The Gruesome
Stock price: 40.56470588235294
P/E ratio: 249.43405402399998
Shares outstanding: 72341663
Book value: 3776470588.235294
P/B ratio: 0.7770531278006231
Market cap (USD): 2934518282.635294
Debt to equity: 0.4059190031152648
Current ratio: 1.8042553191489359
Quick ratio: 0.5714285714285714
Interest coverage ratio: 0.253968253968254
COGS to revenue (%): 94.39144736842104
SG&A to revenue (%): 1.9736842105263157
Free cash flow (dilution-adjusted): 291764705.88235295
Buyback yield (%): 0
Retained earnings: 3274117647.0588236
Inventory turnover: 2.8298816568047336
Receivables turnover: 13.977011494252874
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3508771929824561
FCF margin (%): 4.078947368421052
Revenue growth (%): 9.781351389476661
Rule of 40 score: 13.860298757897713
Financial ratios for BA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 201.32
Shares outstanding: 788302331
Market cap (USD): 158701025276.91998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BA — annual report dated 2022-12-31
Total revenue: 66608000000
Gross profit: 3530000000
Operating income: -3509000000
Net income: -4935000000
Capital expenditures: 1187000000
Operating cash flow: 3512000000
Depreciation & amortization: 1979000000
Net tangible assets: -26251000000
Owner earnings: -4143000000
Buffett classification: The Gruesome
Stock price: 190.49
Shares outstanding: 788302331
Book value: -15848000000
Market cap (USD): 150163711032.19
Debt to equity: -3.6141468955073197
Current ratio: 1.2162195176120463
Quick ratio: 0.34837649358148626
Interest coverage ratio: -1.370167903162827
COGS to revenue (%): 94.70033629594042
R&D to revenue (%): 4.281767955801105
SG&A to revenue (%): 6.286031707902954
Free cash flow (dilution-adjusted): 1565000000
Buyback yield (%): 0
Retained earnings: 29473000000
Inventory turnover: 0.8071297872068176
Receivables turnover: 5.891906236178682
Capitalized R&D asset: 2852000000
ROCI (R&D-adjusted, %): -3.2217768871075485
FCF margin (%): 2.3495676195051645
Rule of 40 score: 2.3495676195051645
Financial ratios for BA — annual report dated 2023-12-31
Total revenue: 77794000000
Gross profit: 7724000000
Operating income: -821000000
Net income: -2222000000
Capital expenditures: 1500000000
Operating cash flow: 5960000000
Depreciation & amortization: 1861000000
Net tangible assets: -27420000000
Owner earnings: -1861000000
Buffett classification: The Gruesome
Stock price: 260.66
Shares outstanding: 788302331
Book value: -17228000000
Market cap (USD): 205478885598.46002
Debt to equity: -3.053343394474112
Current ratio: 1.14033623091613
Quick ratio: 0.30820123764700974
Interest coverage ratio: -0.33387555917039446
COGS to revenue (%): 90.07121371828161
R&D to revenue (%): 4.3409517443504635
SG&A to revenue (%): 6.643185849808468
Free cash flow (dilution-adjusted): 3743000000
Buyback yield (%): 0
Retained earnings: 27251000000
Inventory turnover: 0.8787198555322858
Receivables turnover: 7.030637144148215
Capitalized R&D asset: 5287840000
ROCI (R&D-adjusted, %): 1.0321440795670478
Rosenberg metric: 1.47054698457223
FCF margin (%): 4.81142504563334
Revenue growth (%): 16.79377852510209
Rule of 40 score: 21.60520357073543
Financial ratios for BA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 152.04
Shares outstanding: 788302331
Market cap (USD): 119853486405.23999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 177
Shares outstanding: 788302331
Market cap (USD): 139529512587
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BA — annual report dated 2024-12-31
Total revenue: 66517000000
Gross profit: -1991000000
Operating income: -10824000000
Net income: -11817000000
Capital expenditures: 2181000000
Operating cash flow: -12080000000
Depreciation & amortization: 1836000000
Net tangible assets: -13949000000
Owner earnings: -12162000000
Buffett classification: The Gruesome
Stock price: 177
Shares outstanding: 788302331
Book value: -3914000000
Market cap (USD): 139529512587
Debt to equity: -13.844660194174757
Current ratio: 1.318506767753765
Quick ratio: 0.4166546488390779
Interest coverage ratio: -3.972110091743119
COGS to revenue (%): 102.99321977840252
R&D to revenue (%): 5.730865793706872
SG&A to revenue (%): 7.548446261857871
Free cash flow (dilution-adjusted): -14805000000
Buyback yield (%): 0
Retained earnings: 15362000000
Inventory turnover: 0.7825014277555683
Receivables turnover: 5.938487635032587
Capitalized R&D asset: 7015750000
ROCI (R&D-adjusted, %): -15.624257644144295
Rosenberg metric: -2.8768137400059226
FCF margin (%): -22.25746801569524
Revenue growth (%): -14.495976553461706
Rule of 40 score: -36.75344456915694
Financial ratios for BA — quarterly report dated 2025-03-31
Total revenue: 19496000000
Gross profit: 2417000000
Operating income: 461000000
Net income: -31000000
Capital expenditures: 671000000
Operating cash flow: -1616000000
Depreciation & amortization: 466000000
Net tangible assets: -13320000000
Owner earnings: -236000000
Capex to operating income (%): 145.55314533622558
Buffett classification: The Gruesome
Stock price: 170.55
Shares outstanding: 788302331
Book value: -3325000000
Market cap (USD): 134444962552.05
Debt to equity: -16.125714285714285
Current ratio: 1.2316167248731356
Quick ratio: 0.3722480560325699
Effective tax rate (%): 140.78947368421052
Interest coverage ratio: 0.6511299435028248
COGS to revenue (%): 87.60258514567091
R&D to revenue (%): 4.329093147312269
SG&A to revenue (%): 5.703734099302421
Free cash flow (dilution-adjusted): -2425000000
Buyback yield (%): 0
Retained earnings: 15239000000
Inventory turnover: 0.19173299504922708
Receivables turnover: 1.5675806062555278
Capitalized R&D asset: 844000000
ROCI (R&D-adjusted, %): 1.906837543153764
FCF margin (%): -12.438448912597456
Rule of 40 score: -12.438448912597456
Financial ratios for BA — quarterly report dated 2025-06-30
Total revenue: 22749000000
Gross profit: 2435000000
Operating income: -268000000
Net income: -611000000
Capital expenditures: 426000000
Operating cash flow: 227000000
Depreciation & amortization: 460000000
Net tangible assets: -12117000000
Owner earnings: -577000000
Buffett classification: The Gruesome
Stock price: 209.53
Shares outstanding: 788302331
Book value: -3296000000
Market cap (USD): 165172987414.43
Debt to equity: -16.178094660194176
Current ratio: 1.2314366971057111
Quick ratio: 0.38159727596347315
Interest coverage ratio: -0.37746478873239436
COGS to revenue (%): 89.29623280144182
R&D to revenue (%): 4.0001758319046985
SG&A to revenue (%): 7.8816651281375005
Free cash flow (dilution-adjusted): -319000000
Buyback yield (%): 0
Retained earnings: 14542000000
Inventory turnover: 0.23122716355730596
Receivables turnover: 1.8247373064891312
Capitalized R&D asset: 1475480000
ROCI (R&D-adjusted, %): 0.1077299765674775
Rosenberg metric: 0.02132701421800948
FCF margin (%): -1.4022594399753836
Revenue growth (%): 16.685473943373
Rule of 40 score: 15.283214503397618
Financial ratios for BA — quarterly report dated 2025-09-30
Total revenue: 23270000000
Gross profit: -2375000000
Operating income: -4794000000
Net income: -5337000000
Capital expenditures: 884000000
Operating cash flow: 1123000000
Depreciation & amortization: 491000000
Net tangible assets: -17026000000
Owner earnings: -5730000000
Buffett classification: The Gruesome
Stock price: 215.83
Shares outstanding: 788302331
Book value: -8253000000
Market cap (USD): 170139292099.73
Debt to equity: -6.464679510481037
Current ratio: 1.1820293445859626
Quick ratio: 0.3842960009291162
Interest coverage ratio: -6.9077809798270895
COGS to revenue (%): 110.20627417275462
R&D to revenue (%): 3.8547486033519553
SG&A to revenue (%): 6.540610227761066
Free cash flow (dilution-adjusted): 149000000
Buyback yield (%): 0
Retained earnings: 9118000000
Inventory turnover: 0.31113133151349714
Receivables turnover: 1.884820994654139
Capitalized R&D asset: 1785220000
ROCI (R&D-adjusted, %): -9.860252813527095
Rosenberg metric: -5.285714285714286
FCF margin (%): 0.6403094112591319
Revenue growth (%): 2.290210558705877
Rule of 40 score: 2.930519969965009
Financial ratios for BA — quarterly report dated 2025-12-31
Total revenue: 23948000000
Gross profit: 1812000000
Operating income: -815000000
Net income: 8220000000
Capital expenditures: 879000000
Operating cash flow: 1331000000
Depreciation & amortization: 536000000
Net tangible assets: -13388000000
Owner earnings: 7877000000
Return on net tangible assets (%): -58.83627128772034
Buffett classification: The Gruesome
Stock price: 217.12
P/E ratio: 76.374922849942
Shares outstanding: 788302331
Book value: 5457000000
P/B ratio: 31.364523017540776
Market cap (USD): 171156202106.72
Debt to equity: 9.974894630749496
Current ratio: 1.1881700041622347
Quick ratio: 0.40493918512694815
Effective tax rate (%): 1.1900468806346918
Interest coverage ratio: -1.236722306525038
COGS to revenue (%): 92.43360614665109
R&D to revenue (%): 4.025388341406381
SG&A to revenue (%): 6.944212460330716
Free cash flow (dilution-adjusted): 283000000
Buyback yield (%): 0
Retained earnings: 17252000000
Inventory turnover: 0.2614107393804839
Receivables turnover: 1.9826144548389768
Capitalized R&D asset: 1865290000
ROCI (R&D-adjusted, %): -1.2497588809646072
Rosenberg metric: 4.667781493868451
FCF margin (%): 1.1817270753298814
Revenue growth (%): 2.913622690159003
Rule of 40 score: 4.095349765488884
Financial ratios for BA — annual report dated 2025-12-31
Total revenue: 89463000000
Gross profit: 4289000000
Operating income: -5416000000
Net income: 2238000000
Capital expenditures: 2860000000
Operating cash flow: 1065000000
Depreciation & amortization: 1953000000
Net tangible assets: -13388000000
Owner earnings: 1331000000
Return on net tangible assets (%): -9.941738870630415
Buffett classification: The Gruesome
Stock price: 217.12
P/E ratio: 76.47730210309204
Shares outstanding: 788302331
Book value: 5457000000
P/B ratio: 31.364523017540776
Market cap (USD): 171156202106.72
Debt to equity: 9.974894630749496
Current ratio: 1.1881700041622347
Quick ratio: 0.40493918512694815
Effective tax rate (%): 15.06641366223909
Interest coverage ratio: -1.9545290508841573
COGS to revenue (%): 95.20583928551468
R&D to revenue (%): 4.040776633915697
SG&A to revenue (%): 6.8072834579658625
Free cash flow (dilution-adjusted): -2312000000
Buyback yield (%): 0
Retained earnings: 17252000000
Inventory turnover: 1.0058456051677511
Receivables turnover: 7.406490603526782
Capitalized R&D asset: 7283450000
ROCI (R&D-adjusted, %): -8.014921095779718
Rosenberg metric: 1.6474291710388247
FCF margin (%): -2.5843085968500943
Revenue growth (%): 34.496444517942784
Rule of 40 score: 31.91213592109269
Financial ratios for BRFI.L — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.013243243243243243
Shares outstanding: 164966520
Market cap (USD): 2184691.7513513514
Buyback yield (%): 5346.4156959650645
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRFI.L — annual report dated 2022-09-30
Total revenue: -38976666.666666664
Net income: -40965555.55555555
Capital expenditures: 0
Operating cash flow: 14065555.555555556
Net tangible assets: 336284444.4444444
Owner earnings: -40965555.55555555
Return on net tangible assets (%): -12.181816980334109
Buffett classification: The Gruesome
Stock price: 0.01188888888888889
Shares outstanding: 164966520
Book value: 336284444.4444444
P/B ratio: 0.005832171719708184
Market cap (USD): 1961268.6266666667
Debt to equity: 0
Free cash flow (dilution-adjusted): 14065555.555555556
Buyback yield (%): 0
Receivables turnover: -58.17412935323383
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRFI.L — annual report dated 2023-09-30
Total revenue: 94073170.73170732
Net income: 91287804.87804879
Capital expenditures: 0
Operating cash flow: 19991463.414634146
Net tangible assets: 443412195.1219512
Owner earnings: 91287804.87804879
Return on net tangible assets (%): 20.587571988844825
Buffett classification: The Gruesome
Stock price: 0.015365853658536587
P/E ratio: 0.027767689323501123
Shares outstanding: 164966520
Book value: 443412195.1219512
P/B ratio: 0.005716693029114572
Market cap (USD): 2534851.404878049
Debt to equity: 6.875725389028543e-05
Effective tax rate (%): 1.6734533035597003
COGS to revenue (%): 0
SG&A to revenue (%): 1.3443090484832771
Free cash flow (dilution-adjusted): 19991463.414634146
Buyback yield (%): 0
Receivables turnover: 22.115825688073393
Capitalized R&D asset: 0
FCF margin (%): 21.250972258231783
Rule of 40 score: 21.250972258231783
Financial ratios for BRFI.L — annual report dated 2024-09-30
Total revenue: 81753333.33333333
Net income: 78064000
Capital expenditures: 0
Operating cash flow: 18954666.666666668
Net tangible assets: 541657333.3333334
Owner earnings: 78064000
Return on net tangible assets (%): 14.412063715559405
Buffett classification: The Gruesome
Stock price: 0.017733333333333334
P/E ratio: 0.03747446054519369
Shares outstanding: 164966520
Book value: 541657333.3333334
P/B ratio: 0.005400843130835485
Market cap (USD): 2925406.288
Debt to equity: 0
Effective tax rate (%): 5.038211151995471
COGS to revenue (%): 0
SG&A to revenue (%): 2.0729022262089214
Free cash flow (dilution-adjusted): 18954666.666666668
Buyback yield (%): 0
Receivables turnover: 33.17911255411255
Capitalized R&D asset: 0
FCF margin (%): 23.185191225638103
Revenue growth (%): -13.096015901823533
Rule of 40 score: 10.08917532381457
Financial ratios for BRFI.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 541657333.3333334
Buffett classification: The Gruesome
Stock price: 0.017733333333333334
Shares outstanding: 164966520
Book value: 541657333.3333334
P/B ratio: 0.005400843130835485
Market cap (USD): 2925406.288
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRFI.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 513896103.89610386
Buffett classification: The Gruesome
Stock price: 0.01805194805194805
Shares outstanding: 164966520
Market cap (USD): 2977967.049350649
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRFI.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 603700000
Buffett classification: The Gruesome
Stock price: 0.021756756756756757
Shares outstanding: 164966520
Book value: 603700000
P/B ratio: 0.005945231818202167
Market cap (USD): 3589136.448648649
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRFI.L — annual report dated 2025-09-30
Total revenue: 83905405.4054054
Net income: 79550000
Capital expenditures: 0
Operating cash flow: 22956756.756756756
Net tangible assets: 603700000
Owner earnings: 79550000
Return on net tangible assets (%): 13.177074705979791
Buffett classification: The Gruesome
Stock price: 0.021756756756756757
P/E ratio: 0.04511799432619294
Shares outstanding: 164966520
Book value: 603700000
P/B ratio: 0.005945231818202167
Market cap (USD): 3589136.448648649
Debt to equity: 0
Effective tax rate (%): 6.0459292939277125
COGS to revenue (%): 0
SG&A to revenue (%): 2.2370752133999035
Free cash flow (dilution-adjusted): 22956756.756756756
Buyback yield (%): 4.02867365627841
Receivables turnover: 58.85308056872037
Capitalized R&D asset: 0
FCF margin (%): 27.360283459494283
Revenue growth (%): 2.6323967284580534
Rule of 40 score: 29.992680187952338
Financial ratios for CAF.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 80.35227272727272
Shares outstanding: 8012429
Market cap (USD): 643816880.215909
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAF.PA — annual report dated 2022-12-31
Total revenue: 1141444680.851064
Net income: 393375531.9148936
Capital expenditures: 14240425.531914894
Operating cash flow: -2484821276.5957446
Depreciation & amortization: 50194680.85106383
Net tangible assets: 7823545744.680852
Owner earnings: 429329787.2340426
Return on net tangible assets (%): 5.487662515758145
Buffett classification: The Gruesome
Stock price: 61.37234042553192
P/E ratio: 1.2500561939622419
Shares outstanding: 8012429
Book value: 7823986170.212769
P/B ratio: 0.0628505098968026
Market cap (USD): 491741520.2234043
Debt to equity: 0.06281025874197281
Effective tax rate (%): 19.49328009370639
COGS to revenue (%): 0
SG&A to revenue (%): 18.467265261081977
Free cash flow (dilution-adjusted): -2499061702.12766
Buyback yield (%): 0
Retained earnings: 393375531.9148936
Receivables turnover: 2.327094249921921
Capitalized R&D asset: 0
FCF margin (%): -218.93848594259978
Rule of 40 score: -218.93848594259978
Financial ratios for CAF.PA — annual report dated 2023-12-31
Total revenue: 1070372222.2222222
Net income: 271350000
Capital expenditures: 27164444.444444444
Operating cash flow: -946353333.3333333
Depreciation & amortization: 50786666.666666664
Net tangible assets: 8612154444.444445
Owner earnings: 294972222.22222227
Return on net tangible assets (%): 3.4250688852021676
Buffett classification: The Gruesome
Stock price: 64.85555555555555
P/E ratio: 1.9150563263108327
Shares outstanding: 8012429
Book value: 8612538888.8889
P/B ratio: 0.06033650946004428
Market cap (USD): 519650534.1444444
Debt to equity: 0.03946635944878811
Effective tax rate (%): 19.125804304415357
COGS to revenue (%): 0
SG&A to revenue (%): 21.173008351196625
Free cash flow (dilution-adjusted): -973517777.7777778
Buyback yield (%): 0
Retained earnings: 271350000
Receivables turnover: 1.8274018753284103
Capitalized R&D asset: 0
FCF margin (%): -90.95133053403022
Revenue growth (%): -6.22653553178328
Rule of 40 score: -97.1778660658135
Financial ratios for CAF.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 8540744791.666667
Buffett classification: The Gruesome
Stock price: 64.23958333333334
Shares outstanding: 8012429
Book value: 8541087500
P/B ratio: 0.0602634149864308
Market cap (USD): 514715100.44791675
Debt to equity: 0.05391755831249046
Buyback yield (%): 0
Retained earnings: 199875000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAF.PA — annual report dated 2024-12-31
Total revenue: 932261458.3333334
Net income: 199875000
Capital expenditures: 15708333.333333334
Operating cash flow: -1564471875
Depreciation & amortization: 45756250
Net tangible assets: 8540744791.666667
Owner earnings: 229922916.66666666
Return on net tangible assets (%): 2.692071034495796
Buffett classification: The Gruesome
Stock price: 64.23958333333334
P/E ratio: 2.5751849928601214
Shares outstanding: 8012429
Book value: 8541087500
P/B ratio: 0.0602634149864308
Market cap (USD): 514715100.44791675
Debt to equity: 0.05391755831249046
Effective tax rate (%): 17.417688831504197
COGS to revenue (%): 0
SG&A to revenue (%): 23.24667503192841
Free cash flow (dilution-adjusted): -1580180208.3333335
Buyback yield (%): 0
Retained earnings: 199875000
Receivables turnover: 1.5195914798244348
Capitalized R&D asset: 0
FCF margin (%): -169.49968211260477
Revenue growth (%): -12.903059423772618
Rule of 40 score: -182.4027415363774